Intratumoral injection of allogeneic pro-inflammatory dendritic cells (“ilixadencel”) substantially and sustainably enhanced an otherwise ineffective systemic anti CTLA-4 treatment in...
Dupixent®(dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis First and...
By Rohit Vashisht Competition in the pharmaceutical industry is driving a race to collect the most data and build the...
By Jonathan Wilkins Errors in the pharmaceutical supply chain can lead to late delivery, increased costs and poor-quality products, which...